FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
-31.86%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$304M
AUM Growth
+$304M
(-33%)
Cap. Flow
-$3.6M
Cap. Flow
% of AUM
-1.18%
Top 10 Holdings %
Top 10 Hldgs %
84.19%
Holding
25
New
1
Increased
8
Reduced
7
Closed
3
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$14.4M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$8.75M |
| 3 |
Forte Biosciences
FBRX
|
$4.24M |
| 4 |
Natera
NTRA
|
$3.52M |
| 5 |
Ascendis Pharma
ASND
|
$783K |
Top Sells
| 1 |
Arcus Biosciences
RCUS
|
$15.3M |
| 2 |
Pacific Biosciences
PACB
|
$6.14M |
| 3 |
Sangamo Therapeutics
SGMO
|
$4.5M |
| 4 |
Solid Biosciences
SLDB
|
$3.72M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$2.84M |
Sector Composition
| 1 | Healthcare | 57.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $70.4M | 23.13% | 1,950,477 +242,431 | +14% | +$8.75M |
|
|
IMMU
2
DELISTED
Immunomedics Inc
IMMU
| $38.5M | 12.65% | 2,700,000 +8,271 | +0.3% | +$118K |
|
|
ALDR
3
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $30.2M | 9.9% | 2,942,130 | – | – |
|
|
BPMC
4
DELISTED
Blueprint Medicines
BPMC
| $25.2M | 8.28% | 467,682 +267,682 | +134% | +$14.4M |
|
|
5
Arcus Biosciences
RCUS
$1.13B
| $21.9M | 7.18% | 2,028,876 -1,416,585 | -41% | -$15.3M |
|
|
MYOK
6
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $17.7M | 5.8% | 361,441 -10,859 | -3% | -$531K |
|
|
AIMT
7
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $17M | 5.58% | 709,822 -91,418 | -11% | -$2.19M |
|
|
8
Ascendis Pharma
ASND
$11.8B
| $12.8M | 4.2% | 204,088 +12,500 | +7% | +$783K |
|
|
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
| $12.5M | 4.1% | 1,587,101 +25,061 | +2% | +$197K |
|
|
XLRN
10
DELISTED
Acceleron Pharma Inc.
XLRN
| $10.3M | 3.37% | 235,868 -14,995 | -6% | -$653K |
|
11
Replimune Group
REPL
$422M
| $7.8M | 2.56% | 779,656 | – | – |
|
|
BOLD
12
DELISTED
Audentes Therapeutics, Inc
BOLD
| $6.72M | 2.21% | 315,331 | – | – |
|
|
EPZM
13
DELISTED
Epizyme, Inc
EPZM
| $6.15M | 2.02% | 998,215 +80,500 | +9% | +$496K |
|
|
14
Forte Biosciences
FBRX
$137M
| $5.46M | 1.79% | 665,219 +516,667 | +348% | +$4.24M |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.91M | 1.28% | 105,706 | – | – |
|
|
AKAO
16
DELISTED
Achaogen, Inc.
AKAO
| $3.52M | 1.16% | 2,864,664 +490,246 | +21% | +$603K |
|
|
17
Natera
NTRA
$23.1B
| $3.52M | 1.16% | +252,255 | New | +$3.52M |
|
|
18
Solid Biosciences
SLDB
$427M
| $2.65M | 0.87% | 98,942 -138,942 | -58% | -$3.72M |
|
|
BDSI
19
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.33M | 0.77% | 629,656 | – | – |
|
20
Wave Life Sciences
WVE
$1.53B
| $2.1M | 0.69% | 50,000 | – | – |
|
|
VRNA
21
Verona Pharma
VRNA
$9.16B
| $1.99M | 0.65% | 206,663 -294,220 | -59% | -$2.84M |
|
22
Aclaris Therapeutics
ACRS
$209M
| $1.96M | 0.64% | 265,694 -46,674 | -15% | -$345K |
|
23
Ardelyx
ARDX
$1.53B
| – | – | -130,304 | Closed | -$567K |
|
|
24
Pacific Biosciences
PACB
$393M
| – | – | -1,135,000 | Closed | -$6.14M |
|
|
25
Sangamo Therapeutics
SGMO
$157M
| – | – | -265,605 | Closed | -$4.5M |
|